학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 51건 | 목록 1~10
Academic Journal
Garbayo E; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, Universidad de Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra, IdiSNA, C/Irunlarrea 3, 31008 Pamplona, Spain; Cancer Center Clinica Universidad de Navarra (CCUN). Avenida Pio XII 36, 31008 Pamplona, Spain.; El Moukhtari SH; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, Universidad de Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra, IdiSNA, C/Irunlarrea 3, 31008 Pamplona, Spain.; Rodríguez-Nogales C; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, Universidad de Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra, IdiSNA, C/Irunlarrea 3, 31008 Pamplona, Spain; Cancer Center Clinica Universidad de Navarra (CCUN). Avenida Pio XII 36, 31008 Pamplona, Spain.; Agirre X; Instituto de Investigación Sanitaria de Navarra, IdiSNA, C/Irunlarrea 3, 31008 Pamplona, Spain; Cancer Center Clinica Universidad de Navarra (CCUN). Avenida Pio XII 36, 31008 Pamplona, Spain; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pío XII 55, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.; Rodriguez-Madoz JR; Instituto de Investigación Sanitaria de Navarra, IdiSNA, C/Irunlarrea 3, 31008 Pamplona, Spain; Cancer Center Clinica Universidad de Navarra (CCUN). Avenida Pio XII 36, 31008 Pamplona, Spain; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pío XII 55, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.; Rodriguez-Marquez P; Instituto de Investigación Sanitaria de Navarra, IdiSNA, C/Irunlarrea 3, 31008 Pamplona, Spain; Cancer Center Clinica Universidad de Navarra (CCUN). Avenida Pio XII 36, 31008 Pamplona, Spain; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pío XII 55, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.; Prósper F; Instituto de Investigación Sanitaria de Navarra, IdiSNA, C/Irunlarrea 3, 31008 Pamplona, Spain; Cancer Center Clinica Universidad de Navarra (CCUN). Avenida Pio XII 36, 31008 Pamplona, Spain; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pío XII 55, 31008 Pamplona, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain; Departmento de Hematología and CCUN, Clínica Universidad de Navarra, University of Navarra, Avenida Pío XII 36, 31008 Pamplona, Spain.; Couvreur P; Institut Galien Paris-Sud, UMR CNRS 8612, Université Paris-Saclay, Orsay Cedex, France. Electronic address: patrick.couvreur@universite-paris-saclay.fr.; Blanco-Prieto MJ; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, Universidad de Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra, IdiSNA, C/Irunlarrea 3, 31008 Pamplona, Spain; Cancer Center Clinica Universidad de Navarra (CCUN). Avenida Pio XII 36, 31008 Pamplona, Spain. Electronic address: mjblanco@unav.es.
Publisher: Elsevier Science Publishers, B.V Country of Publication: Netherlands NLM ID: 8710523 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8294 (Electronic) Linking ISSN: 0169409X NLM ISO Abbreviation: Adv Drug Deliv Rev Subsets: MEDLINE
Academic Journal
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Academic Journal
Palacios-Berraquero ML; Hematology and Cell Therapy Department. Cancer Center Clinica Universidad de Navarra (CUN). IdiSNA., Pamplona, Spain.; Rodriguez-Marquez P; Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain.; Calleja-Cervantes ME; Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain.; Berastegui N; CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Zabaleta A; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicadas (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Burgos L; Universidad de Navarra, Pamplona, Spain.; Alignani D; Centro de Investigacion Medica Alplicada. Universidad de Navarra., Pamplona, Spain.; San Martín-Úriz P; Foundation for Applied Medical Research, University of Navarra, Pamplona, Spain.; Vilas-Zornoza A; Centro de Investigacion Medica Aplicada, Pamplona, Spain.; Rodriguez-Diaz S; Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain.; Inoges SI; University of Navarra Hospital, Pamplona, Spain.; López-Diaz-de-Cerio A; Clinica Universidad de Navarra.; Huerga S; Clínica Universidad de Navarra, Pamplona, Spain.; Tamariz-Amador LE; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplo, Pamplona, Spain.; Rifon JJ; University Clinic of Navarra, Pamplona, Spain.; Alfonso-Pierola A; University Clinic of Navarra, Pamplona, Spain.; Lasarte JJ; Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain.; Paiva B; Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBERONC (CB16/12/00369), Pamplona, Spain.; Hernaez M; CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Rodriguez-Otero P; Cancer Center Clínica Universidad de Navarra, Pamplona, Spain.; San-Miguel JF; Clinica Universidad de Navarra, CCUN, Centro de Investigación, Medica Aplicada (CIMA), Instituto de Investigación, Sanitaria de Navarra (IDISNA, CIBERONC), CIBER-ONC CB16/12/00369, Pamplona, Spain, Pamplona, Navarra, Spain.; Ezponda T; Foundation for Applied Medical Research, University of Navarra, Pamplona, Spain.; Rodriguez-Madoz JR; Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain.; Prosper F; Clinica Universidad de Navarra, Pamplona, Spain.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Sánchez-Moreno I; Immunology and Immunotherapy Program, Center for Applied Medical Research (CIMA), University of Navarra, IdISNA, Pamplona, Spain.; Lasarte-Cia A; Immunology and Immunotherapy Program, Center for Applied Medical Research (CIMA), University of Navarra, IdISNA, Pamplona, Spain.; Martín-Otal C; Immunology and Immunotherapy Program, Center for Applied Medical Research (CIMA), University of Navarra, IdISNA, Pamplona, Spain.; Casares N; Immunology and Immunotherapy Program, Center for Applied Medical Research (CIMA), University of Navarra, IdISNA, Pamplona, Spain.; Navarro F; Immunology and Immunotherapy Program, Center for Applied Medical Research (CIMA), University of Navarra, IdISNA, Pamplona, Spain.; Gorraiz M; Immunology and Immunotherapy Program, Center for Applied Medical Research (CIMA), University of Navarra, IdISNA, Pamplona, Spain.; Sarrión P; Immunology and Immunotherapy Program, Center for Applied Medical Research (CIMA), University of Navarra, IdISNA, Pamplona, Spain.; Hervas-Stubbs S; Immunology and Immunotherapy Program, Center for Applied Medical Research (CIMA), University of Navarra, IdISNA, Pamplona, Spain.; Cancer Center Universidad de Navarra (CCUN), Pamplona, Spain.; Jordana L; Hemato-Oncology Program, Centre for Applied Medical Research (CIMA), University of Navarra, IdiSNA, Pamplona, Spain.; Rodriguez-Madoz JR; Cancer Center Universidad de Navarra (CCUN), Pamplona, Spain.; Hemato-Oncology Program, Centre for Applied Medical Research (CIMA), University of Navarra, IdiSNA, Pamplona, Spain.; San Miguel J; Cancer Center Universidad de Navarra (CCUN), Pamplona, Spain.; Hematology and Cell Therapy Department, Clínica Universidad de Navarra, (CUN), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Prosper F; Cancer Center Universidad de Navarra (CCUN), Pamplona, Spain.; Hemato-Oncology Program, Centre for Applied Medical Research (CIMA), University of Navarra, IdiSNA, Pamplona, Spain.; Hematology and Cell Therapy Department, Clínica Universidad de Navarra, (CUN), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Lasarte JJ; Immunology and Immunotherapy Program, Center for Applied Medical Research (CIMA), University of Navarra, IdISNA, Pamplona, Spain jjlasarte@unav.es.; Cancer Center Universidad de Navarra (CCUN), Pamplona, Spain.; Lozano T; Immunology and Immunotherapy Program, Center for Applied Medical Research (CIMA), University of Navarra, IdISNA, Pamplona, Spain.; Cancer Center Universidad de Navarra (CCUN), Pamplona, Spain.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Calviño C; Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain.; Ceballos C; Hematology Department, Hospital Universitario de Navarra, IdiSNA, Pamplona, Spain.; Alfonso A; Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain.; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.; Jauregui P; Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain.; Calleja-Cervantes ME; Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; Computational Biology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; San Martin-Uriz P; Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; Rodriguez-Marquez P; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.; Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; Martin-Mallo A; Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; Iglesias E; Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; Abizanda G; Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; Rodriguez-Diaz S; Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; Martinez-Turrillas R; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.; Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; Illarramendi J; Hematology Department, Hospital Universitario de Navarra, IdiSNA, Pamplona, Spain.; Viguria MC; Hematology Department, Hospital Universitario de Navarra, IdiSNA, Pamplona, Spain.; Redondo M; Hematology Department, Hospital Universitario de Navarra, IdiSNA, Pamplona, Spain.; Rifon J; Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain.; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.; Villar S; Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain.; Lasarte JJ; Immunology and Immunotherapy Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; Inoges S; Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain.; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.; Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; Immunology and Immunotherapy Department, Clinica Universidad de Navarra, Pamplona, Spain.; Lopez-Diaz de Cerio A; Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain.; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.; Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; Immunology and Immunotherapy Department, Clinica Universidad de Navarra, Pamplona, Spain.; Hernaez M; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.; Computational Biology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; Data Science and Artificial Intelligence Institute (DATAI), Universidad de Navarra, Pamplona, Spain.; Prosper F; Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain.; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.; Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; Rodriguez-Madoz JR; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.; Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.; Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
Moya-Jódar M; Program of Regenerative Medicine, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona 31008, Spain.; Ullate-Agote A; Program of Regenerative Medicine, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Advanced Genomics Laboratory, Program of Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Barlabé P; Program of Regenerative Medicine, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona 31008, Spain.; Rodríguez-Madoz JR; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), IDISNA, University of Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Abizanda G; Program of Regenerative Medicine, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona 31008, Spain.; Barreda C; Program of Regenerative Medicine, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona 31008, Spain.; Carvajal-Vergara X; Program of Regenerative Medicine, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona 31008, Spain.; Vilas-Zornoza A; Advanced Genomics Laboratory, Program of Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Romero JP; Advanced Genomics Laboratory, Program of Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; 10x Genomics, 6230 Stoneridge Mall Road, Pleasanton, CA 94588, USA.; Garate L; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), IDISNA, University of Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Agirre X; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), IDISNA, University of Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Coppiello G; Program of Regenerative Medicine, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona 31008, Spain.; Prósper F; Program of Regenerative Medicine, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona 31008, Spain; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), IDISNA, University of Navarra, Pamplona, Spain; Hematology Department, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain. Electronic address: fprosper@unav.es.; Aranguren XL; Program of Regenerative Medicine, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona 31008, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona 31008, Spain. Electronic address: xlaranguren@unav.es.
Publisher: Cell Press Country of Publication: United States NLM ID: 101611300 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-6711 (Electronic) Linking ISSN: 22136711 NLM ISO Abbreviation: Stem Cell Reports Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Rodriguez-Madoz JR
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어